Intensive therapy effectively delays the onset and slows the progression of diabetic retinopathy, nephropathy, and neuropathy in patients with IDDM.
Biostatistics and Biomedical Science Relative Risk Estimates and Tests for Two Independent Groups Sample Size, Power, and Efficiency Stratified-Adjusted Analysis for Two Indepen...
The reduction in the risk of progressive retinopathy and nephropathy resulting from intensive therapy in patients with type 1 diabetes persists for at least four years, despite ...
Intensive therapy during the DCCT resulted in decreased progression of intima-media thickness six years after the end of the trial.
h-index: Number of publications with at least h citations each.